Medical device company financing brought in $977 million, a decrease over Q1’s $1.1 billion. Device acquisition activity was up to $4.6 billion, yet only one deal surpassed the billion-dollar mark. With late-stage financing again leading, diagnostics funding together brought in $336 million, an 11% increase over Q1. For the first time since Q1 2011, the diagnostics M&A dollar total moved up instead of down, with $7 billion in acquisitions and five of the seven transactions topping $100 million.
Although medical device companies had a strong opening in 2012 — they brought in $1.1 billion in Q1— the second quarter saw a dip in the money raised. While it is certainly a respectable amount, the $977 million that did come in was still substantially less even looking back a year ago at the same period of time, when $1.7 billion was achieved.
Exhibit 1